Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs. Read more about Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs.
Extracellular vesicles and their nucleic acids for biomarker discovery. Read more about Extracellular vesicles and their nucleic acids for biomarker discovery.
Therapeutic targeting of cathepsin C: from pathophysiology to treatment. Read more about Therapeutic targeting of cathepsin C: from pathophysiology to treatment.
Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms. Read more about Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms.
Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Read more about Bevacizumab-induced hypertension: Clinical presentation and molecular understanding.
Looking back, to the future of circulating tumor cells. Read more about Looking back, to the future of circulating tumor cells.
Integration of molecular targeted therapy with radiation in head and neck cancer. Read more about Integration of molecular targeted therapy with radiation in head and neck cancer.
Signaling through the epidermal growth factor receptor during the development of malignancy. Read more about Signaling through the epidermal growth factor receptor during the development of malignancy.
Acquisition of inhibitor-sensitive protein kinases through protein design. Read more about Acquisition of inhibitor-sensitive protein kinases through protein design.
Understanding and manipulating O6-methylguanine-DNA methyltransferase expression. Read more about Understanding and manipulating O6-methylguanine-DNA methyltransferase expression.
